Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Blanco, G
  • Puiggros, A
  • Baliakas, P
  • Athanasiadou, A
  • Garcia-Malo, M
  • Collado, R
  • Xochelli, A
  • Rodriguez-Rivera, M
  • Ortega, M
  • Calasanz, MJ
  • Luno, E
  • Vargas, M
  • Grau, J
  • Martinez-Laperche, C
  • Valiente, A
  • Anagnostopoulos, A
  • Gimeno, E
  • Abella, E
  • Stalika, E
  • Hernandez-Rivas, JM
  • Ortuno, FJ
  • Robles, D
  • Ferrer, A
  • Ivars, D
  • Gonzalez, M
  • Bosch, F
  • Abrisqueta, P
  • Stamatopoulos, K
  • Espinet, B

Grupos

Abstract

Patients with chronic lymphocytic leukemia (CLL) harboring TP53 aberrations (TP53abs; chromosome 17p deletion and/or TP53 mutation) exhibit an unfavorable clinical outcome. Chromosome 8 abnormalities, namely losses of 8p (8p-) and gains of 8q (8q+) have been suggested to aggravate the outcome of patients with TP53abs. However, the reported series were small, thus hindering definitive conclusions. To gain insight into this issue, we assessed a series of 101 CLL patients harboring TP53 disruption. The frequency of 8p- and 8q+ was 14.7% and 17.8% respectively. Both were associated with a significantly (P < 0.05) higher incidence of a complex karyotype (CK, >= 3 abnormalities) detected by chromosome banding analysis (CBA) compared to cases with normal 8p (N-8p) and 8q (N-8q), respectively. In univariate analysis for 10- year overall survival (OS), 8p- (P = 0.002), 8q+ (P = 0.012) and CK (P = 0.009) were associated with shorter OS. However, in multivariate analysis only CK (HR = 2.47, P = 0.027) maintained independent significance, being associated with a dismal outcome regardless of chromosome 8 abnormalities. In conclusion, our results highlight the association of chromosome 8 abnormalities with CK amongst CLL patients with TP53abs, while also revealing that CK can further aggravate the prognosis of this aggressive subgroup.

Datos de la publicación

ISSN/ISSNe:
1949-2553, 1949-2553

Oncotarget  IMPACT JOURNALS LLC

Tipo:
Article
Páginas:
80916-80924
PubMed:
27821812
Factor de Impacto:
1,994 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 25

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • CLL; TP53 aberrations; chromosome 8 abnormalities; complex karyotype; prognosis

Campos de Estudio

Cita

Compartir